Cholinesterase Inhibitors and Memantine Use in the National

 
   Lead Investigator:    Dana Meranus
   Institution      :    NACC
   E-Mail           :    dmeranus@uw.edu
   Proposal ID      :    190


   Publications:


1  Meranus D, Monsell S, Thomas G, Kukull W
   Cholinesterase Inhibitors and Memantine Use in the National Alzheimer's Coordinating Center's Uniform Data Set: A Longitudinal Assessment of Real-World Medication Use in Dementia
   Abstract  Alzheimers Dement,8:P711,2012,

   PUBLISHED





   Proposal Description:
   Aims: (1) Describe the use of cholinesterase inhibitors and memantine in NACC dementia patients with AD, VaD, DLB, and mixed dementia (AD and VaD)    (2) Describe patients who discontinue use of cholinesterase inhibitors and memantine    (2) Assess changes in cognition/behavior after medication prescription